Showing results (21-30 of 776) with videos related to
Sort By:
Pageof 78
Oncogene|September 19, 2003
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Martin Sattler, et al.Experimental Hematology|April 15, 2003
Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cellsStephanie Greenstein, Nancy L Krett, Yoshihiro Kurosawa, et al.The Journal of Biological Chemistry|April 1, 2003
JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cellsDharminder Chauhan, Guilan Li, Teru Hideshima, et al.Molecular Cancer Therapeutics|December 14, 2002
The biological sequelae of stromal cell-derived factor-1alpha in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.BMC Biology|November 1, 2011
Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130CasDharminder Chauhan, Kenneth C AndersonOncogene|April 20, 2004
Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib/Proteasome inhibitor PS-341Dharminder Chauhan, Guilan Li, Teru Hideshima, et al.Blood|November 17, 2007
Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myelomaDharminder Chauhan, Ajita Singh, Mohan Brahmandam, et al.Current Treatment Options in Oncology|April 30, 2004
An update of novel therapeutic approaches for multiple myelomaPaul Richardson, Teru Hideshima, Kenneth C AndersonBlood Reviews|December 4, 2010
Multiple myeloma: biology of the diseaseAnuj Mahindra, Teru Hideshima, Kenneth C AndersonInternational Journal of Hematology|April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedsideTakeshi Harada, Teru Hideshima, Kenneth C AndersonPageof 78